Namely, systemic lupus is associated with hematologic malignancies and lymphoma risks, in which OPN deficiency accelerated tumor incidence with B cells expressing BCL2, c-MYC, and activated Stat3 signaling (95). Here, SPP1 is linked to lymphoma.